Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 625 of 1467 entries
View as:

18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

Phase: N/A Priority: Normal
NCT ID: NCT00103649 Org: User:
Start: 11/30/03 End: 10/31/07 Due: 10/31/08

Study of SAR240550 (BSI-201) in Combination With Gemcitabine/Carboplatin, in Patients With Metastatic Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01045304 Org: User:
Start: 02/28/10 End: 11/30/12 Due: 11/30/13

Safety and Efficacy of Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01751308 Org: User:
Start: 02/28/13 End: 02/29/16 Due: 02/28/17

Study of Non Inferiority Bi-Profenid® 200mg Versus Bi-Profenid® 300mg Among Patients Presenting of the Post-traumatic or Rheumatologic Acute Affections of the Locomotor Apparatus (BIPROPAIN)

Phase: N/A Priority: Normal
NCT ID: NCT00810121 Org: User:
Start: 11/30/08 End: 06/30/09 Due: 06/30/10

OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT00130403 Org: User:
Start: 03/31/04 End: 03/31/07 Due: 03/31/08

Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder (SIRIUS)

Phase: N/A Priority: Normal
NCT ID: NCT00385307 Org: User:
Start: 09/30/06 End: 11/30/07 Due: 11/30/08

Open Label, Phase I ZD6474 Head and Neck Cancer Study

Phase: N/A Priority: Normal
NCT ID: NCT00450138 Org: User:
Start: 12/31/06 End: 11/30/11 Due: 11/30/12

Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01312961 Org: User:
Start: 03/31/11 End: 10/31/12 Due: 10/31/13

A Study Comparing the Effectiveness and Safety of Teriflunomide and Interferon Beta-1a in Patients With Relapsing Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00883337 Org: User:
Start: 04/30/09 End: 05/31/15 Due: 05/31/16

Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/Flutter

Phase: N/A Priority: Normal
NCT ID: NCT00233441 Org: User:
Start: 12/31/04 End: 05/31/06 Due: 05/31/07

Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS

Phase: N/A Priority: Normal
NCT ID: NCT00335452 Org: User:
Start: 06/30/06 End: 09/30/09 Due: 09/30/10

Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT00046501 Org: User:
Start: 11/30/02 End: - Due: -

Study of Valproate in Young Patients Suffering From Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT00385411 Org: User:
Start: 03/31/06 End: 10/31/08 Due: 10/31/09

Efficacy and Safety Study of Intra-articular Multiple Doses of Icatibant in Patients With Painful Knee Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT00303056 Org: User:
Start: 02/28/06 End: 07/31/07 Due: 07/31/08

A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202)

Phase: N/A Priority: Normal
NCT ID: NCT04914897 Org: User:
Start: 09/23/21 End: 10/17/24 Due: 10/17/25

Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan

Phase: N/A Priority: Normal
NCT ID: NCT02941367 Org: User:
Start: 02/23/17 End: 08/04/17 Due: 08/04/18

Comparison of a Basal Plus One Insulin Regimen With a Biphasic Insulin Regimen in Type 2 Diabetes Patients

Phase: N/A Priority: Normal
NCT ID: NCT00965549 Org: User:
Start: 07/31/09 End: 12/31/12 Due: 12/31/13

Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03860844 Org: User:
Start: 08/06/19 End: 05/26/23 Due: 05/26/24

Dupilumab in Japanese Patients With Chronic Rhinosinusitis With Nasal Polyp (SINUS-M52)

Phase: N/A Priority: Normal
NCT ID: NCT05049122 Org: User:
Start: 10/22/21 End: 07/05/23 Due: 07/05/24

Safety And Tolerability Of Lixisenatide In Monotherapy In Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01960179 Org: User:
Start: 11/30/13 End: 03/31/15 Due: 03/31/16

Japanese Study of the Combined Administration of Docetaxel With Prednisolone for Metastatic Hormone Refractory Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00723086 Org: User:
Start: 05/31/05 End: 09/30/08 Due: 09/30/09

Superiority of Glimepiride Over Sitagliptin in Naive Type 2 Diabetes Patients

Phase: N/A Priority: Normal
NCT ID: NCT00957060 Org: User:
Start: 07/31/09 End: 10/31/10 Due: 10/31/11

Safety, Tolerability and Pharmacokinetics of SAR113945 in Japanese Patients With Knee Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT01511549 Org: User:
Start: 01/31/12 End: 09/30/12 Due: 09/30/13

Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01391533 Org: User:
Start: 07/31/11 End: 04/30/16 Due: 04/30/17

Phase I Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study, Safety, Tolerability and Immunogenicity

Phase: N/A Priority: Normal
NCT ID: NCT00772954 Org: User:
Start: 03/31/06 End: 06/30/06 Due: 06/30/07